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Abstract
Background: Gastric cancer is one of the most common malignancies in the world and is the second most
common cause of cancer-related death in Korea. Colorectal metastases from gastric adenocarcinoma are known to
be very rare. We report an unusual case of rectal metastasis of gastric adenocarcinoma.
Case presentation: We report a case of a 43-year-old female patient with gastric cancer who first presented with
epigastric pain. The endoscopic and radiologic findings were suggestive of Borrmann type III advanced gastric
cancer with linitis plastica. Radical total gastrectomy with D2 lymph node dissection was performed. The pathology
report was AJCC TNM Stage II gastric adenocarcinoma (T3N0M0). On follow up at 34 months after surgery, the
patient complained of difficulty in defecation. On colonoscopy, a hard, indurated extraluminal mass was detected 7
cm proximal to the anal verge. The biopsy demonstrated chronic nonspecific colitis. Abdominal CT, rectal MRI and
PET-CT revealed rectal metastasis from gastric cancer. Laparoscopic ultralow anterior resection with diverting
ileostomy was performed. The pathology report was metastatic adenocarcinoma, and this diagnosis was identical
to the gastric pathology reported in the previous pathology report. The patient was discharged after the 11
th
postoperative day with no adverse events.
Conclusion: Rectal metastasis from gastric cancer is known to be very rare. However, metastatic gastric
adenocarcinoma should be considered as a differential diagnosis for patients presenting with a colorectal mass
and a past history of gastric cancer.
Background
Gastric cancer is one of the most common malignancies
in the world and is the second most common cause of
cancer-related death in Korea [1]. The known routes of
distant metastasis after curative resection include: lym-
phatics (Virchow’s node), peritoneal seeding (Kruken-
berg’s tumor or Plummer’s rectal shelf) or hematogenous
spread (Schnitzler’s metastasis) [2,3].
Colonic metastases from gastric adenocarcinoma are
k n o w nt ob ev e r yr a r ea n ds u c hah e m a t o g e n o u sr e c u r -
rence pattern of advanced gastric cancer with lymph
node-negative and absence of lymphovascular invasion
in the pathology after curative R0 resection has rarely
been described.
We report an unusual case of rectal metastasis from
gastric adenocarcinoma.
Case Presentation
A 43-year-old woman who first presented with epigas-
tric pain was diagnosed with gastric cancer. She had no
family history of gastric cancer. Her past medical history
revealed that she had undergone Cesarean section once.
Laboratory findings showed mild anemia, with a hemo-
globin level of 10.9 g/dL (reference range 12.3-16.5 g/
dL). The endoscopic and radiologic findings revealed
that the gastric mass was Borrmann type III advanced
gastric cancer with linitis plastica.
She had undergone radical total gastrectomy with D2
lymph node dissection, and splenectomy in December
2007. The final pathology report after surgery demon-
strated a diffuse, poorly differentiated adenocarcinoma.
The surgical resection margins were clear. Thirty-five
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tumor-free, and spleen was not involved. Lymphovascu-
lar invasion was absent, although, perineural invasion
was noted. The TNM staging according to the 6
th edi-
tion American Joint Committee on Cancer (AJCC) was
stage II (T3N0M0)[4]. She was managed as an outpati-
ent on a regular basis through physical examination,
CBC and chemistry profile including vitamin B12 with
monitoring every 3 months, abdominal CT every 6
months, and gastroduodenoscopy annually for 3 years.
She had shown no evidence of disease recurrence in the
33 months prior to this episode. At thirty-four months
after surgery, during a routine check-up, the patient
complained of difficulty with defecation and constipa-
tion since the last.
1 month. On digital rectal examination and colono-
scopy, hard induration and stenosis of the rectum, with
an extraluminal mass 7 cm proximal to the anal verge,
with edematous, erythematous, and nodular mucosa was
detected (Figure 1). The colonoscopy-guided biopsy
demonstrated chronic nonspecific erosive colitis.
On laboratory examination, serum carcinoembryonic
antigen (CEA) level was 3.3 ng/mL (normal range: 5.0
ng/mL or less). The other serum tumor markers, includ-
ing CA 19-9, were also within their normal ranges.
Abdominal computed tomography (CT) and rectal
MRI revealed a 5 cm in length concentric wall thicken-
ing with enhancement in the mid-rectum about 6 cm
proximal to the anal verge, and it had a target-like
appearance (Figure 2). No evidence of tumor infiltration
was observed around the perirectal fat plane. Overlying
peritoneum showed thickening and enhancement sug-
gestive of peritoneal seeding.
Her past medical history and radiologic findings sug-
gested that metastasis to the rectum from gastric malig-
nancy was more likely than primary rectal malignancy.
On subsequent F-18-fluoro-deoxy-glucose (FDG) posi-
tron emission tomography (PET) scan, focal hypermeta-
bolic lesion with the standardized uptake value (SUV) of
7.6 was detected in the upper rectum (Figure 3). No
abnormal hypermetabolic activity was noted in the area
of previous gastrectomy and anastomotic sites.
Finally, it was postulated that the rectal tumor was a
metastatic tumor from gastric malignancy and peritoneal
seeding in the pelvic cavity. Laparoscopic low anterior
resection with diverting ileostomy was performed.
Briefly, the abdomen was entered using open (Hasson)
method, and an 11 mm supraumbilical optic port was
placed. A 12-mm port was placed in both the right and
left lower quadrants and two 5-mm ports were placed
about 10 cm proximal to each 12-mm port. The abdo-
men was insufflated with CO2 gas to a pressure of 12
mmHg. The moderate adhesions resulting from the pre-
vious gastrectomy were dissected and lysed with an
ultrasonic dissector. After careful inspection of the liver
and entire abdomen, a laparoscopic biopsy of the perito-
neal mass was performed, and frozen sections were
obtained for analysis. For operation of the rectum, a
medial-to-lateral approach for laparoscopic colectomy
was chosen and a high ligation of the inferior mesen-
teric artery and vein was performed, and the dissection
was begun. Laparoscopic total mesorectal excision up to
2 cm distal to the rectal tumor was accomplished, and
double stapling using endoscopic linear staplers and a
circular stapler was performed for rectal transection and
primary anastomosis. All procedures were in keeping
with the oncologic principles.
The OCTO port wound protector and retractor sys-
tem (Dalim Medical, Daejun, Korea) and cylindrical
vinyl film were used to cover the minilaparotomy for
protection against cancer cell dissemination during spe-
cimen extraction. A diverting loop ileostomy was
Figure 1 Colonoscopic view of the circumferential rectal wall thickening located 7 cm above the dentate line and showing an
edematous, erythematous, and nodular mucosa.
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moperitoneum (Figure 4).
Intraoperative fresh frozen sections of paraaortic
lymph nodes and peritoneal mass were obtained for
analysis, and the findings were negative for malignancy.
The fresh specimen was about 17 cm in length on
gross examination, and the rectal tumor size was about
4×4 . 5c m
2 in size. The configuration of the lesion was
of an ulceroinfiltrative mass. The safety resection mar-
gins were 10 cm proximally, 2 cm distally. Both the
resected surgical margins were free from tumor cells.
The circumferential margin after excision of the rectal
tumor was 1.1 mm. The type of differentiation was of a
poorly differentiated metastatic gastric cancer, invading
all layers of the rectal wall up to pericolic soft tissue
with focal mucosal invasion. Thirty-five lymph nodes
were harvested, and all of them were found to be free
from tumor cell invasion.
The immunohistochemical staining for cytokeratin 7
(CK7), cytokeratin 20 (CK20), c-erb B2 and CDX2 were
negative (Figure 5). The pathology report showed meta-
static adenocarcinoma.
Oral feeding was started on the 3
rd postoperative day,
and the patient was discharged after the 11
th postopera-
tive day with no adverse events. After rectal resection,
the patient was still being followed up for chemotherapy
with the FOLFOX-4 regimen (Oxaliplatin 85 mg/m
2 IV
on day 1, leucovorin 200 mg/m
2 IV on day 1, 5-FU 400
mg/m
2 IV bolus on day 1, and 5-FU 1,200 mg/m
2 con-
t i n u o u sI Vi n f u s i o no nd a y1a n d2 )s t a r t i n gf r o m
December 2010. Her clinical course is being observed
and she is exhibiting stable disease while the 12 cycles
of the FOLFOX-4 regimen are being continued.
Conclusion
The incidence of gastric cancer throughout the world is
still high, and the incidence rate is increasing, especially
in many Asian countries including Korea [1]. In clinical
practice, lymph node metastasis, hematogenous spread,
peritoneal seeding, and locoregional recurrence are the
major routes for recurrence of gastric adenocarcinoma
after curative resection [5,6].
Intestinal metastasis from gastric cancer is not com-
mon, although the most common cause of secondary
neoplastic infiltration of the colon is gastric linitis plas-
tica [7,8]. The main route of metastatic neoplastic infil-
tration involving the gastrointestinal tract is known to
be hematogenous such that metastatic deposits invade
the submucosal lymphatics and extend to form a linitis
plastica appearance [9]. In the present study, although it
is not clear whether this tumor was a genuine hemato-
genous metastasis to the rectum or it could be carcino-
matosis associated with rectal invasion. Intraoperative
fresh frozen sections of peritoneal mass were negative
for malignancy. In addition, no grossly suspicious mass
or nodules of carcinomatosis peritonei were found dur-
ing laparoscopic exploration.
Also, the patterns of metastases in the intestinal and
diffuse types of gastric cancer are known to be different,
and the diffuse type of gastric cancer demonstrated a
wider dissemination than the intestinal type. The intest-
inal type involved the liver more frequently [10]. Perito-
neal metastasis, lymphatic permeation of the lung, and
Krukenberg tumors were more common in the cases of
diffuse type of gastric cancer. In the present study, the
histology of primary gastric cancer was diffuse, poorly
differentiated adenocarcinoma with linitis plastica that
metastasized to the rectum three years later, and was
comparable with atypical metastasis of gastric cancer.
The endoscopic features of luminal metastases are vari-
able, but the typical characteristic features are diffuse cir-
cumferential wall thickening and stiffness which mimick
those of linitis plastica such that the term secondary linitis
plastica of the rectum has been used [11]. The overlying
Figure 2 A. Axial abdominal CT demonstrates concentric wall thickening, particularly in the inner enhancing layer with a target
pattern. B. MRI scan shows no evidence of tumor infiltration around the perirectal fat plane.
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malignancy on mucosal biopsy, as was seen in the present
study. A possible explanation for this may be that luminal
metastases to the colorectum are usually known to pre-
serve the mucosa, and the findings of colonoscopic biopsy
may often be invalid [12,13].
CT appears to be the most feasible technique for
detecting intestinal metastasis from gastric adenocarci-
noma [12]. Intestinal metastasis from gastric cancer,
especially of the linitis plastica type, most commonly
shows target-like long segmental wall thickening with a
characteristically thick inner enhancing layer on the
helical CT. Jang et al reported that this type of metasta-
sis also showed frequent association of peritoneal seed-
ing and rare involvement of the liver, and emphasized
that for CT of patients with gastric carcinoma or a past
history of the disease, scrutiny of bowel for possible
metastasis is needed.
The laparoscopic surgery has been an alternative to
conventional open surgery in the treatment of colorectal
Figure 3 FDG-PET showed hypermetabolism in the rectum. The mean standardized uptake value calculated by FDG-PET for rectal tumor was
7.6.
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come of laparoscopic colectomy [14,15]. In the present
study, the surgery for rectal metastasis was performed
laparoscopically. The issue of concomitant moderate
degree of intra-abdominal adhesions after a previous
history of radical gastrectomy and splenectomy has been
overcome via advancement in laparoscopic surgical
instruments and techniques used by experienced color-
ectal surgeons.
The clinical utility of CDX2 was confirmed to be fairly
specific for the identification of adenocarcinoma of the
gastrointestinal tract, particularly colorectal adenocarci-
noma, in the primary and metastatic setting [16]. In
55% of gastric carcinomas, CDX2 expression was found
by immunohistochemistry, with higher levels of CDX2
expressions noted in carcinomas with intestinal-type
morphology [17]. In addition, the prognosis of gastric
carcinoma patients with CDX2 positive expression is
significantly better than that in patients with CDX2
negative expression [18]. In the present study, CDX2
negativity and cytokeratin 20 negativity suggested a
non-colorectal origin of the tumor, rather than a color-
ectal malignancy.
After rectal resection, we used the FOLFOX regimen for
systemic therapy due to our institutional preference.
Other regimens such as DCF (docetaxel, cisplatin, and 5-
FU), ECF (epirubicin, cisplatin, and 5-FU), irinotecan plus
cisplatin, with other modifications could also be used.
In conclusion, we experienced a rare case of hemato-
genous rectal metastatic carcinoma from gastric adeno-
carcinoma which was treated successfully by
laparoscopic surgery.
Colorectal metastasis from gastric cancer may occur,
although it is very rare. When the symptoms of change
in bowel habits such as abrupt hematochezia, or consti-
pation are noticed, the possibility of metastases to the
colon and rectum should be suspected, and the impor-
tance of endoscopic and CT surveillance for metastatic
sites in the colon and rectum should be emphasized at
postoperative check up during the follow-up period.
Consent
Written informed consent was obtained from the
patients for publication of this report and any accompa-
nying images. A copy of the written consent is available
for review with the Editor-in-Chief of this journal.
Figure 4 Postoperative abdomen and surgical specimen of the rectal lesion. The laparoscopy was performed via scar of the previous
gastrectomy.
Figure 5 Section of the rectal specimen showing metastatic gastric adenocarcinoma. A, B. Hematoxylin and eosin stain C. CDX2
immunostain shows negativity.
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